Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054961 · ClinicalTrials.gov registry record
Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 34
- Enrollment target
NCT03054961: Completed study, sponsored by Medical College of Wisconsin.
NCT03054961 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03054961 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to describe the relationship of regional cerebral oximetry and cytoximetry, measured using near-infrared spectroscopy, with seizure activity in the periictal period in children with epilepsy.
Primary Outcome
Regional cerebral saturation of oxygen and/or cytochrome oxidase redox state will change prior, during, and after onset of seizure activity when compared to non-seizure side of brain.
Interventions
- DEVICE Near-infrared spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2023-06-07 |
What the finished NCT03054961 record still lists
NCT03054961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Near-infrared spectroscopy is the first listed.
NCT03054961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03054961 about?
NCT03054961 is a clinical study titled "Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study". The purpose of this pilot study is to describe the relationship of regional cerebral oximetry and cytoximetry, measured using near-infrared spectroscopy, with seizure activity in the periictal period in children with epilepsy.
What is the current status of trial NCT03054961?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2017-02-10. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT03054961?
The interventions under investigation include: Near-infrared spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT03054961?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI